You are here

AusPAR: ChAdOx1-S

Related information

How to access a pdf or Word document

*Large file warning: Attempting to open large files over the Internet within the browser window may cause problems. It is strongly recommended you download this document to your own computer and open from there.

Australian Public Assessment Report

16 February 2021
AusPAR Details
Active Ingredient
Product Name
COVID-19 Vaccine AstraZeneca
AstraZeneca Pty Ltd
Submission Number
PM 2020 06115 1-2
Submission Type
New biological entity
Approved for provisional registration
AusPAR Date
15 February 2021
Publication Date

16 February 2021